Parametric Portfolio Associates’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.83M Buy
341,584
+175,361
+105% +$1.24M ﹤0.01% 2227
2021
Q4
$1.13M Sell
166,223
-2,175
-1% -$14.3K ﹤0.01% 2730
2021
Q3
$893K Buy
168,398
+2,676
+2% +$14.6K ﹤0.01% 2846
2021
Q2
$953K Sell
165,722
-41,533
-20% -$214K ﹤0.01% 2792
2021
Q1
$955K Buy
207,255
+87,726
+73% +$349K ﹤0.01% 3182
2020
Q4
$399K Buy
119,529
+2,344
+2% +$7.88K ﹤0.01% 3475
2020
Q3
$348K Buy
117,185
+29,487
+34% +$115K ﹤0.01% 3428
2020
Q2
$405K Buy
87,698
+38,345
+78% +$172K ﹤0.01% 3356
2020
Q1
$190K Sell
49,353
-12,655
-20% -$51.9K ﹤0.01% 3571
2019
Q4
$233K Buy
62,008
+49,429
+393% +$231K ﹤0.01% 3680
2019
Q3
$67K Buy
+12,579
New +$67K ﹤0.01% 3881
2019
Q2
Sell
-186,708
Closed -$952K 3961
2019
Q1
$952K Buy
+186,708
New +$549K ﹤0.01% 3058
2018
Q1
Sell
-261,325
Closed -$1.02M 3937
2017
Q4
$1.02M Buy
+261,325
New +$863K ﹤0.01% 3012

Other funds holding CPRX